Status:
COMPLETED
Risky Decision Making in Methamphetamine Users: The Role of Opioid Blockade
Lead Sponsor:
Oregon Health and Science University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Methamphetamine Abuse
HIV
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
The purpose of this protocol is to learn more about impulsive decision making in people who use methamphetamines. The investigators would like to know if a medication called naltrexone changes how peo...
Eligibility Criteria
Inclusion
- Summary
- Diagnostic and Statistical Manual (DSM)-IV Methamphetamine Dependence
- Deemed healthy enough to participate by study physician
- Age 18-55
- Right handed
- English-speaking
- Summary
Exclusion
- Current opioid use in the last 30 days; opioid abuse or dependence within past 5 years
- Pregnancy
- MRI contraindications (e.g. metal in head).
- The research is conducted in Portland, OR.
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT01822132
Start Date
May 1 2013
End Date
March 1 2015
Last Update
March 5 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health & Science University
Portland, Oregon, United States, 97239
2
Portland VA Medical Center
Portland, Oregon, United States, 97239